Cargando…

Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease

BACKGROUND: There are many factors that can affect dialysis adequacy; such as the type of vascular access, filter type, device used, and the dose, and rout of erythropoietin stimulation agents (ESA) used. The aim of this study was investigating factors affecting Hemodialysis adequacy in cohort of Ir...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahdadi, Hosein, Balouchi, Abbas, Sepehri, Zahra, Rafiemanesh, Hosein, Magbri, Awad, Keikhaie, Fereshteh, Shahakzehi, Ahmad, Sarjou, Azizullah Arbabi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Center of Science and Education 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016363/
https://www.ncbi.nlm.nih.gov/pubmed/27045416
http://dx.doi.org/10.5539/gjhs.v8n8p50
_version_ 1782452558921465856
author Shahdadi, Hosein
Balouchi, Abbas
Sepehri, Zahra
Rafiemanesh, Hosein
Magbri, Awad
Keikhaie, Fereshteh
Shahakzehi, Ahmad
Sarjou, Azizullah Arbabi
author_facet Shahdadi, Hosein
Balouchi, Abbas
Sepehri, Zahra
Rafiemanesh, Hosein
Magbri, Awad
Keikhaie, Fereshteh
Shahakzehi, Ahmad
Sarjou, Azizullah Arbabi
author_sort Shahdadi, Hosein
collection PubMed
description BACKGROUND: There are many factors that can affect dialysis adequacy; such as the type of vascular access, filter type, device used, and the dose, and rout of erythropoietin stimulation agents (ESA) used. The aim of this study was investigating factors affecting Hemodialysis adequacy in cohort of Iranian patient with end stage renal disease (ESRD). METHODS: This is a cross-sectional study conducted on 133 Hemodialysis patients referred to two dialysis units in Sistan-Baluchistan province in the cities of Zabol and Iranshahr, Iran. We have looked at, (the effects of the type of vascular access, the filter type, the device used, and the dose, route of delivery, and the type of ESA used) on Hemodialysis adequacy. Dialysis adequacy was calculated using kt/v formula, two-part information questionnaire including demographic data which also including access type, filter type, device used for hemodialysis (HD), type of Eprex injection, route of administration, blood groups and hemoglobin response to ESA were utilized. The data was analyzed using the SPSS v16 statistical software. Descriptive statistical methods, Mann-Whitney statistical test, and multiple regressions were used when applicable. RESULTS: The range of calculated dialysis adequacy is 0.28 to 2.39 (units of adequacy of dialysis). 76.7% of patients are being dialyzed via AVF and 23.3% of patients used central venous catheters (CVC). There was no statistical significant difference between dialysis adequacy, vascular access type, device used for HD (Fresenius and B. Braun), and the filter used for HD (p> 0.05). However, a significant difference was observed between the adequacy of dialysis and Eprex injection and patients’ time of dialysis (p <0.05). CONCLUSION: Subcutaneous ESA (Eprex) injection and dialysis shift (being dialyzed in the morning) can have positive impact on dialysis adequacy. Patients should be educated on the facts that the type of device used for HD and the vascular access used has no significant effects on dialysis adequacy.
format Online
Article
Text
id pubmed-5016363
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Canadian Center of Science and Education
record_format MEDLINE/PubMed
spelling pubmed-50163632016-09-13 Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease Shahdadi, Hosein Balouchi, Abbas Sepehri, Zahra Rafiemanesh, Hosein Magbri, Awad Keikhaie, Fereshteh Shahakzehi, Ahmad Sarjou, Azizullah Arbabi Glob J Health Sci Article BACKGROUND: There are many factors that can affect dialysis adequacy; such as the type of vascular access, filter type, device used, and the dose, and rout of erythropoietin stimulation agents (ESA) used. The aim of this study was investigating factors affecting Hemodialysis adequacy in cohort of Iranian patient with end stage renal disease (ESRD). METHODS: This is a cross-sectional study conducted on 133 Hemodialysis patients referred to two dialysis units in Sistan-Baluchistan province in the cities of Zabol and Iranshahr, Iran. We have looked at, (the effects of the type of vascular access, the filter type, the device used, and the dose, route of delivery, and the type of ESA used) on Hemodialysis adequacy. Dialysis adequacy was calculated using kt/v formula, two-part information questionnaire including demographic data which also including access type, filter type, device used for hemodialysis (HD), type of Eprex injection, route of administration, blood groups and hemoglobin response to ESA were utilized. The data was analyzed using the SPSS v16 statistical software. Descriptive statistical methods, Mann-Whitney statistical test, and multiple regressions were used when applicable. RESULTS: The range of calculated dialysis adequacy is 0.28 to 2.39 (units of adequacy of dialysis). 76.7% of patients are being dialyzed via AVF and 23.3% of patients used central venous catheters (CVC). There was no statistical significant difference between dialysis adequacy, vascular access type, device used for HD (Fresenius and B. Braun), and the filter used for HD (p> 0.05). However, a significant difference was observed between the adequacy of dialysis and Eprex injection and patients’ time of dialysis (p <0.05). CONCLUSION: Subcutaneous ESA (Eprex) injection and dialysis shift (being dialyzed in the morning) can have positive impact on dialysis adequacy. Patients should be educated on the facts that the type of device used for HD and the vascular access used has no significant effects on dialysis adequacy. Canadian Center of Science and Education 2016-08 2015-12-17 /pmc/articles/PMC5016363/ /pubmed/27045416 http://dx.doi.org/10.5539/gjhs.v8n8p50 Text en Copyright: © Canadian Center of Science and Education http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Shahdadi, Hosein
Balouchi, Abbas
Sepehri, Zahra
Rafiemanesh, Hosein
Magbri, Awad
Keikhaie, Fereshteh
Shahakzehi, Ahmad
Sarjou, Azizullah Arbabi
Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease
title Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease
title_full Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease
title_fullStr Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease
title_full_unstemmed Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease
title_short Factors Affecting Hemodialysis Adequacy in Cohort of Iranian Patient with End Stage Renal Disease
title_sort factors affecting hemodialysis adequacy in cohort of iranian patient with end stage renal disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016363/
https://www.ncbi.nlm.nih.gov/pubmed/27045416
http://dx.doi.org/10.5539/gjhs.v8n8p50
work_keys_str_mv AT shahdadihosein factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease
AT balouchiabbas factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease
AT sepehrizahra factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease
AT rafiemaneshhosein factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease
AT magbriawad factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease
AT keikhaiefereshteh factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease
AT shahakzehiahmad factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease
AT sarjouazizullaharbabi factorsaffectinghemodialysisadequacyincohortofiranianpatientwithendstagerenaldisease